Clinical trial
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
NCT00037752 · University of Tennessee, Other · Completed
Key facts
| NCT number | NCT00037752 |
|---|---|
| Title | Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates |
| Official title | Use of Sibutramine in Smoking Cessation |
| Acronym | SUCCESS |
| Lead sponsor | University of Tennessee, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Obesity |
| Intervention type | Behavioral, Drug |
| Interventions | Sibutramine, Behavioral Smoking Cessation Program |
| Enrollment | 436 |
| Start date | Sep 1, 2002 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 21, 2002 |
| Last update posted | May 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: